Org 5593952368Mazarinvägen 31Research and experimental development on natural sciences and engineering · NACE 7210Est. 20221 employees
Revenue 2024
SEK 12K
EBITDA margin
-3847.8%
Equity ratio
84.5%
Financial strength
Net profit 2024
SEK -521K
1 employees
EBITDA — year on yearSEK millionsKey figuresAnnual report 2024
Revenue
SEK 12K
—
EBITDA
SEK -468K
—
Net profit
SEK -521K
—
Total assets
SEK 4,9M
—
Equity
SEK 4,2M
—
Employees
1
—
Company information
Legal name
Soma Genomics AB
Org number
5593952368
Legal form
Aktiebolag
NACE code
7210 · Research and experimental development on natural sciences and engineering
Founded
5 september 2022
Share capital
SEK 1 450 000
Employees
1 (FTE)
VAT registered
Yes
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
Firman tecknas av styrelsen
Company purpose
Bolaget ska bedriva utveckling, tillverkning och försäljning inom medicintekniska produkter för in vitrodiagnostik, samt annan därmed förenlig verksamhet.
Contact
Address
Mazarinvägen 31
Email
christer.ericsson@somagenomics.com
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.